AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
EFFICIENT NEAR IR SENSITIZATION OF NANOCRYSTALLINE TIO2 FILMS BY RUTHENIUM PHTHALOCYANINES
Authors: NAZEERUDDIN MK HUMPHRYBAKER R GRATZEL M MURRER BA
Citation: Mk. Nazeeruddin et al., EFFICIENT NEAR IR SENSITIZATION OF NANOCRYSTALLINE TIO2 FILMS BY RUTHENIUM PHTHALOCYANINES, Chemical communications, (6), 1998, pp. 719-720
CHEMICAL, BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITY OF THE NOVEL STERICALLY HINDERED PLATINUM COORDINATION COMPLEX, CIS-[AMMINEDICHLORO(2-METHYLPYRIDINE)] PLATINUM(II) (AMD473)
Authors: HOLFORD J RAYNAUD F MURRER BA GRIMALDI K HARTLEY JA ABRAMS M KELLAND LR
Citation: J. Holford et al., CHEMICAL, BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITY OF THE NOVEL STERICALLY HINDERED PLATINUM COORDINATION COMPLEX, CIS-[AMMINEDICHLORO(2-METHYLPYRIDINE)] PLATINUM(II) (AMD473), Anti-cancer drug design, 13(1), 1998, pp. 1-18
IN-VITRO CIRCUMVENTION OF CISPLATIN RESISTANCE BY THE NOVEL STERICALLY HINDERED PLATINUM COMPLEX AMD473
Authors: HOLFORD J SHARP SY MURRER BA ABRAMS M KELLAND LR
Citation: J. Holford et al., IN-VITRO CIRCUMVENTION OF CISPLATIN RESISTANCE BY THE NOVEL STERICALLY HINDERED PLATINUM COMPLEX AMD473, British Journal of Cancer, 77(3), 1998, pp. 366-373
KINETICS OF NITRIC-OXIDE SCAVENGING BY RUTHENIUM(III) POLYAMINOCARBOXYLATES - NOVEL THERAPEUTIC AGENTS FOR SEPTIC SHOCK
Authors: DAVIES NA WILSON MT SLADE E FRICKER SP MURRER BA POWELL NA HENDERSON GR
Citation: Na. Davies et al., KINETICS OF NITRIC-OXIDE SCAVENGING BY RUTHENIUM(III) POLYAMINOCARBOXYLATES - NOVEL THERAPEUTIC AGENTS FOR SEPTIC SHOCK, Chemical communications, (1), 1997, pp. 47-48
CIS-AMINEDICHLORO(2-METHYLPYRIDINE)PLATINUM(II) (AMD473), A NOVEL STERICALLY HINDERED PLATINUM COMPLEX - IN-VIVO ACTIVITY, TOXICOLOGY, AND PHARMACOKINETICS IN MICE
Authors: RAYNAUD FI BOXALL FE GODDARD PM VALENTI M JONES M MURRER BA ABRAMS M KELLAND LR
Citation: Fi. Raynaud et al., CIS-AMINEDICHLORO(2-METHYLPYRIDINE)PLATINUM(II) (AMD473), A NOVEL STERICALLY HINDERED PLATINUM COMPLEX - IN-VIVO ACTIVITY, TOXICOLOGY, AND PHARMACOKINETICS IN MICE, Clinical cancer research, 3(11), 1997, pp. 2063-2074
THE SYNTHESIS OF PT-191 LABELED JM216, AN ORALLY-ACTIVE PLATINUM ANTITUMOR AGENT
Authors: BATES PI SHARMA HL MURRER BA BERNARD CFJ MCAULIFFE CA
Citation: Pi. Bates et al., THE SYNTHESIS OF PT-191 LABELED JM216, AN ORALLY-ACTIVE PLATINUM ANTITUMOR AGENT, Applied radiation and isotopes, 48(4), 1997, pp. 469-476
RUTHENIUM COMPLEXES AS NITRIC-OXIDE SCAVENGERS - A POTENTIAL THERAPEUTIC APPROACH TO NITRIC OXIDE-MEDIATED DISEASES
Authors: FRICKER SP SLADE E POWELL NA VAUGHAN OJ HENDERSON GR MURRER BA MEGSON IL BISLAND SK FLITNEY FW
Citation: Sp. Fricker et al., RUTHENIUM COMPLEXES AS NITRIC-OXIDE SCAVENGERS - A POTENTIAL THERAPEUTIC APPROACH TO NITRIC OXIDE-MEDIATED DISEASES, British Journal of Pharmacology, 122(7), 1997, pp. 1441-1449
USE OF LUMINESCENT GOLD COMPOUNDS IN THE DESIGN OF THIN-FILM OXYGEN SENSORS
Authors: MILLS A LEPRE A THEOBALD BRC SLADE E MURRER BA
Citation: A. Mills et al., USE OF LUMINESCENT GOLD COMPOUNDS IN THE DESIGN OF THIN-FILM OXYGEN SENSORS, Analytical chemistry, 69(14), 1997, pp. 2842-2847
CONFORMATIONAL FLEXIBILITY AND ITS POTENTIAL, INFLUENCE ON METABOLIC REACTIONS FOR THE ANTITUMOR COMPOUND INE-BD-BIS(BUTYRATO)-CF-DICHLORO-E-CYCLOHEXYLAMINE PLATINUM(IV)
Authors: NEIDLE S MURRER BA BARNARD CFJ
Citation: S. Neidle et al., CONFORMATIONAL FLEXIBILITY AND ITS POTENTIAL, INFLUENCE ON METABOLIC REACTIONS FOR THE ANTITUMOR COMPOUND INE-BD-BIS(BUTYRATO)-CF-DICHLORO-E-CYCLOHEXYLAMINE PLATINUM(IV), Bioorganic & medicinal chemistry letters, 6(4), 1996, pp. 421-426
THE TISSUE DISTRIBUTION IN BALB C MICE OF C-14-LABELED JM216, AN ORALLY-ACTIVE PLATINUM ANTITUMOR COMPOUND/
Authors: BATES PI SHARMA HL MURRER BA MCAULIFFE CA
Citation: Pi. Bates et al., THE TISSUE DISTRIBUTION IN BALB C MICE OF C-14-LABELED JM216, AN ORALLY-ACTIVE PLATINUM ANTITUMOR COMPOUND/, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 170-175
BIOTRANSFORMATION OF THE PLATINUM DRUG JM216 FOLLOWING ORAL-ADMINISTRATION TO CANCER-PATIENTS
Authors: RAYNAUD FI MISTRY P DONAGHUE A POON GK KELLAND LR BARNARD CFJ MURRER BA HARRAP KR
Citation: Fi. Raynaud et al., BIOTRANSFORMATION OF THE PLATINUM DRUG JM216 FOLLOWING ORAL-ADMINISTRATION TO CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 38(2), 1996, pp. 155-162
METABOLISM, PROTEIN-BINDING AND IN-VIVO ACTIVITY OF THE ORAL PLATINUMDRUG JM216 AND ITS BIOTRANSFORMATION PRODUCTS
Authors: RAYNAUD FI BOXALL FE GODDARD P BARNARD CF MURRER BA KELLAND LR
Citation: Fi. Raynaud et al., METABOLISM, PROTEIN-BINDING AND IN-VIVO ACTIVITY OF THE ORAL PLATINUMDRUG JM216 AND ITS BIOTRANSFORMATION PRODUCTS, Anticancer research, 16(4A), 1996, pp. 1857-1862
NOVEL TRANS PLATINUM COMPLEXES - COMPARATIVE IN-VITRO AND IN-VIVO ACTIVITY AGAINST PLATINUM-SENSITIVE AND RESISTANT MURINE TUMORS
Authors: GODDARD PM ORR RM VALENTI MR BARNARD CFJ MURRER BA KELLAND LR HARRAP KR
Citation: Pm. Goddard et al., NOVEL TRANS PLATINUM COMPLEXES - COMPARATIVE IN-VITRO AND IN-VIVO ACTIVITY AGAINST PLATINUM-SENSITIVE AND RESISTANT MURINE TUMORS, Anticancer research, 16(1), 1996, pp. 33-38
METABOLIC STUDIES OF AN ORALLY-ACTIVE PLATINUM ANTICANCER DRUG BY LIQUID-CHROMATOGRAPHY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY
Authors: POON GK RAYNAUD FI MISTRY P ODELL DE KELLAND LR HARRAP KR BARNARD CFJ MURRER BA
Citation: Gk. Poon et al., METABOLIC STUDIES OF AN ORALLY-ACTIVE PLATINUM ANTICANCER DRUG BY LIQUID-CHROMATOGRAPHY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY, Journal of chromatography, 712(1), 1995, pp. 61-66
DETERMINATION OF METABOLITES OF A NOVEL PLATINUM ANTICANCER DRUG JM216 IN HUMAN PLASMA ULTRAFILTRATES
Authors: POON GK MISTRY P RAYNAUD FI HARRAP KR MURRER BA BARNARD CFJ
Citation: Gk. Poon et al., DETERMINATION OF METABOLITES OF A NOVEL PLATINUM ANTICANCER DRUG JM216 IN HUMAN PLASMA ULTRAFILTRATES, Journal of pharmaceutical and biomedical analysis, 13(12), 1995, pp. 1493-1498
ETATO)AMMINEDICHLORO(CYCLOHEXYLAMINE)PLATINUM(IV), AN ORALLY-ACTIVE ANTICANCER DRUG
Authors: NEIDLE S SNOOK CF MURRER BA BARNARD CFJ
Citation: S. Neidle et al., ETATO)AMMINEDICHLORO(CYCLOHEXYLAMINE)PLATINUM(IV), AN ORALLY-ACTIVE ANTICANCER DRUG, Acta crystallographica. Section C, Crystal structure communications, 51, 1995, pp. 822-824
SYNTHESIS AND IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF A SERIES OF TRANS PLATINUM ANTITUMOR COMPLEXES
Authors: KELLAND LR BARNARD CFJ EVANS IG MURRER BA THEOBALD BRC WYER SB GODDARD PM JONES M VALENTI M BRYANT A ROGERS PM HARRAP KR
Citation: Lr. Kelland et al., SYNTHESIS AND IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF A SERIES OF TRANS PLATINUM ANTITUMOR COMPLEXES, Journal of medicinal chemistry, 38(16), 1995, pp. 3016-3024
DNA-BINDING PROPERTIES OF NOVEL CIS AND TRANS PLATINUM-BASED ANTICANCER AGENTS IN 2 HUMAN OVARIAN-CARCINOMA CELL-LINES
Authors: MELLISH KJ BARNARD CFJ MURRER BA KELLAND LR
Citation: Kj. Mellish et al., DNA-BINDING PROPERTIES OF NOVEL CIS AND TRANS PLATINUM-BASED ANTICANCER AGENTS IN 2 HUMAN OVARIAN-CARCINOMA CELL-LINES, International journal of cancer, 62(6), 1995, pp. 717-723
CARBOXYLATION OF KINETICALLY INERT PLATINUM(IV) HYDROXY COMPLEXES - AN ENTREE INTO ORALLY-ACTIVE PLATINUM(IV) ANTITUMOR AGENTS
Authors: GIANDOMENICO CM ABRAMS MJ MURRER BA VOLLANO JF RHEINHEIMER MI WYER SB BOSSARD GE HIGGINS JD
Citation: Cm. Giandomenico et al., CARBOXYLATION OF KINETICALLY INERT PLATINUM(IV) HYDROXY COMPLEXES - AN ENTREE INTO ORALLY-ACTIVE PLATINUM(IV) ANTITUMOR AGENTS, Inorganic chemistry, 34(5), 1995, pp. 1015-1021
PRECLINICAL TOXICOLOGY AND TISSUE PLATINUM DISTRIBUTION OF NOVEL ORALANTITUMOR PLATINUM COMPLEXES - AMMINE AMINE PLATINUM(IV) DICARBOXYLATES/
Authors: MCKEAGE MJ MORGAN SE BOXALL FE MURRER BA HARD GC HARRAP KR
Citation: Mj. Mckeage et al., PRECLINICAL TOXICOLOGY AND TISSUE PLATINUM DISTRIBUTION OF NOVEL ORALANTITUMOR PLATINUM COMPLEXES - AMMINE AMINE PLATINUM(IV) DICARBOXYLATES/, Cancer chemotherapy and pharmacology, 33(6), 1994, pp. 497-503
A NOVEL TRANS-PLATINUM COORDINATION COMPLEX POSSESSING IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY
Authors: KELLAND LR BARNARD CFJ MELLISH KJ JONES M GODDARD PM VALENTI M BRYANT A MURRER BA HARRAP KR
Citation: Lr. Kelland et al., A NOVEL TRANS-PLATINUM COORDINATION COMPLEX POSSESSING IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY, Cancer research, 54(21), 1994, pp. 5618-5622
A NOVEL TRANS-PLATINUM COORDINATION COMPLEX POSSESSING IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY
Authors: KELLAND LR BARNARD CFJ MELLISH KJ JONES M GODDARD PM VALENTI M BRYANT A MURRER BA HARRAP KR
Citation: Lr. Kelland et al., A NOVEL TRANS-PLATINUM COORDINATION COMPLEX POSSESSING IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY, Cancer research, 54(21), 1994, pp. 5618-5622
EVALUATION OF NOVEL AMMINE AMINE PLATINUM(IV) DICARBOXYLATES IN L1210MURINE LEUKEMIA-CELLS SENSITIVE AND RESISTANT TO CISPLATIN, TETRAPLATIN OR CARBOPLATIN/
Authors: ORR RM ONEILL CF NICOLSON MC BARNARD CFJ MURRER BA GIANDOMENICO CM VOLLANO JF HARRAP KR
Citation: Rm. Orr et al., EVALUATION OF NOVEL AMMINE AMINE PLATINUM(IV) DICARBOXYLATES IN L1210MURINE LEUKEMIA-CELLS SENSITIVE AND RESISTANT TO CISPLATIN, TETRAPLATIN OR CARBOPLATIN/, British Journal of Cancer, 70(3), 1994, pp. 415-420
ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED AMMINE AMINE PLATINUM (IV) DICARBOXYLATE COMPLEXES AGAINST A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS
Authors: KELLAND LR JONES M GWYNNE JJ VALENTI M MURRER BA BARNARD CFJ VOLLANO JF GIANDOMENICO CM ABRAMS MJ HARRAP KR
Citation: Lr. Kelland et al., ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED AMMINE AMINE PLATINUM (IV) DICARBOXYLATE COMPLEXES AGAINST A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS, International journal of oncology, 2(6), 1993, pp. 1043-1048
METAL-COMPOUNDS IN THERAPY AND DIAGNOSIS
Authors: ABRAMS MJ MURRER BA
Citation: Mj. Abrams et Ba. Murrer, METAL-COMPOUNDS IN THERAPY AND DIAGNOSIS, Science, 261(5122), 1993, pp. 725-730
Risultati: 1-25 | 26-27